Ming-cai Qiu

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo

Ping Liu, Fengao Li, Ming-cai Qiu et al. · Diabetes Research and Clinical Practice · 2014 · 69 citations

Medicine, Immunology, Pathology +14

STAT1/3 and ERK1/2 Synergistically Regulate Cardiac Fibrosis Induced by High Glucose

Bin Dai, Meng Cui, Mei Zhu et al. · Cellular Physiology and Biochemistry · 2013 · 63 citations · Full text

Life Sciences, Biochemistry, Physiology +13

1,25(OH)2D3 provides protection against diabetic kidney disease by downregulating the TLR4-MyD88-NF-κB pathway

Ping Liu, Fengao Li, Xiaoyan Xu et al. · Experimental and Molecular Pathology · 2020 · 30 citations

Medicine, Immunology, Nephrology +11

Autoimmune hypophysitis may eventually become empty sella.

Hua Gao, You-you Gu, Ming-cai Qiu · PubMed · 2013 · 25 citations

Life Sciences, Endocrinology, Neuroscience +17